> For the complete documentation index, see [llms.txt](https://www.thiamine.wiki/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.thiamine.wiki/biochemistry/ttfd-fursultiamine.md).

# ttfd fursultiamine

{% hint style="info" %}
**Section:** Complete Biochemistry → Thiamine Derivatives\
**Reading level:** Technical, with a plain-language summary\
**Last reviewed:** October 2026 · **Evidence status:** Moderate (pharmacokinetics); limited (clinical outcomes)
{% endhint %}

## Summary

**Thiamine tetrahydrofurfuryl disulfide (TTFD)**, known by the international non-proprietary name **fursultiamine**, is a synthetic thiamine derivative developed in Japan in the 1960s. It was modelled on **allithiamine**, the naturally occurring thiamine disulfide formed in garlic. In TTFD, the ring-opened form of thiamine is linked through a disulfide bond to a tetrahydrofurfuryl group, making it uncharged and lipophilic.

TTFD is absorbed by passive diffusion and is converted back to thiamine inside cells through reduction of its disulfide bond. It raises blood thiamine more than thiamine salts do, and animal studies suggest it increases brain thiamine. It has a long history of clinical use in Japan, but **controlled clinical evidence is limited**, consisting mostly of small and open-label studies.

## Key facts

| Property                               | Detail                                                                                         |
| -------------------------------------- | ---------------------------------------------------------------------------------------------- |
| **Chemical name**                      | Thiamine tetrahydrofurfuryl disulfide                                                          |
| **International non-proprietary name** | Fursultiamine                                                                                  |
| **Formula**                            | C₁₇H₂₆N₄O₃S₂                                                                                   |
| **Molar mass**                         | ≈398.5 g/mol                                                                                   |
| **CAS number**                         | 804-30-8                                                                                       |
| **Class**                              | Disulfide derivative                                                                           |
| **Activation**                         | Reduction of the disulfide bond inside cells (thiol–disulfide exchange, e.g. with glutathione) |
| **Distinctive feature**                | Garlic-like odour from the released thiol                                                      |

## History

* **Early 1950s:** Fujiwara and colleagues in Kyoto discover **allithiamine**, formed when thiamine reacts with allicin from garlic. It is better absorbed than thiamine.
* **1950s–1960s:** Japanese chemists synthesize a series of thiamine disulfides, including thiamine propyl disulfide (prosultiamine) and TTFD.
* **1960s onward:** TTFD is used clinically in Japan, including for thiamine deficiency and fatigue.
* **Later decades:** TTFD attracts interest outside Japan, notably through the work of American physician Derrick Lonsdale, who studied it in several conditions.

## Mechanism of activation

{% stepper %}
{% step %}

### Absorption

Being uncharged and lipophilic, TTFD crosses the intestinal wall and cell membranes largely by **passive diffusion**, independent of THTR-1 and THTR-2.
{% endstep %}

{% step %}

### Reduction

Inside cells, the disulfide bond is cleaved by thiol–disulfide exchange with **glutathione** and other reducing systems. This releases the thiamine thiol form and **tetrahydrofurfuryl mercaptan**.
{% endstep %}

{% step %}

### Ring closure

The thiol form closes spontaneously to **thiamine**, which is then phosphorylated to TPP.
{% endstep %}

{% step %}

### By-product metabolism

Tetrahydrofurfuryl mercaptan is further metabolized and excreted. Volatile sulfur metabolites account for the characteristic garlic-like odour of breath, sweat or urine reported by some users.
{% endstep %}
{% endstepper %}

Because activation consumes reducing equivalents, it has been suggested that TTFD might transiently affect cellular glutathione balance. This has not been well studied in humans.

## Pharmacokinetics

* Human studies show **higher blood thiamine and TPP** after oral TTFD than after equivalent thiamine salts.
* In a comparative human study, TTFD produced **lower blood levels than benfotiamine** but higher levels than thiamine disulfide.
* Animal studies report increases in thiamine compounds in tissues, including the brain. Rigorous modern brain pharmacokinetic data in humans are lacking.

## Clinical evidence

| Area                                 | Study type                           | Findings                                                                | Strength                                              |
| ------------------------------------ | ------------------------------------ | ----------------------------------------------------------------------- | ----------------------------------------------------- |
| **Thiamine deficiency and beriberi** | Long-standing clinical use in Japan  | Effective as a thiamine source                                          | **Moderate** (clinical experience; few modern trials) |
| **Alzheimer's disease**              | Small open-label study (1996)        | Mild improvement in cognitive scores in some patients with mild disease | **Very limited**                                      |
| **Autism spectrum disorder**         | Open-label pilot (2002), 10 children | Some clinical improvement reported; no control group                    | **Very limited**                                      |
| **Fatigue and exercise**             | Small human studies; rat studies     | Reduced fatigue measures and improved energy metabolism in some studies | **Limited**                                           |
| **Other neurological conditions**    | Case reports and series              | Variable                                                                | **Very limited**                                      |

{% hint style="warning" %}
**Evidence note:** most published human studies of TTFD are small, open-label or uncontrolled. Positive findings from such studies are hypothesis-generating and are vulnerable to placebo effects, natural variation and selection bias. No large randomized controlled trials of TTFD for any chronic condition were found.
{% endhint %}

## Safety

* TTFD has been used clinically for decades in Japan and has generally been reported as **well tolerated**.
* The most commonly reported effect is a **garlic-like odour**. Gastrointestinal discomfort and other minor effects have been reported.
* Formal long-term safety studies at high doses are limited.

## Comparison with other derivatives

| Feature                                    | TTFD               | Sulbutiamine                      | Benfotiamine                                  |
| ------------------------------------------ | ------------------ | --------------------------------- | --------------------------------------------- |
| Class                                      | Disulfide          | Disulfide dimer with ester groups | S-acyl phosphate                              |
| Lipophilicity of the administered compound | High               | Very high                         | Low (lipophilic only after dephosphorylation) |
| Activation                                 | Reduction          | Reduction and ester hydrolysis    | Dephosphorylation, then thioester hydrolysis  |
| Brain thiamine (animal data)               | Increases reported | Increases shown                   | Little or no increase                         |
| Controlled human trials                    | Few                | Few                               | Several                                       |

## Evidence quality

| Claim type                                | Strength                                             |
| ----------------------------------------- | ---------------------------------------------------- |
| Chemistry and activation by reduction     | **Strong**                                           |
| Higher blood thiamine than thiamine salts | **Moderate to strong**                               |
| Brain penetration                         | **Moderate** (animal data)                           |
| Clinical benefit in chronic conditions    | **Limited**                                          |
| Safety                                    | **Moderate** (long clinical use; few formal studies) |

## Open questions

* Does TTFD raise brain thiamine in humans, and to what extent compared with other derivatives?
* Does its activation by reduction affect cellular redox balance meaningfully?
* Would well-designed controlled trials confirm benefits suggested by open-label studies?

## Related pages

* [Thiamine Derivatives (Overview)](broken://pages/44390ee2e231e4f690942c9b807cab9f6eb7272d)
* [Sulbutiamine](broken://pages/03906e8b2674229295f1625dddf1cfbb518b9b6b)
* [Benfotiamine](broken://pages/75effe2f75d8702a4645b72eb76b7a3b69392e6d)
* [Thiamine Structure](broken://pages/e97e22d3de70d018c7c19aa407e5feb03d96c2a0)

## References

1. Fujiwara M. Allithiamine and its properties. *Journal of Nutritional Science and Vitaminology*. 1976;22(Suppl):57–62.
2. Lonsdale D. Thiamine tetrahydrofurfuryl disulfide: a little known therapeutic agent. *Medical Science Monitor*. 2004;10(9):RA199–RA203.
3. Greb A, Bitsch R. Comparative bioavailability of various thiamine derivatives after oral administration. *International Journal of Clinical Pharmacology and Therapeutics*. 1998;36(4):216–221.
4. Mimori Y, Katsuoka H, Nakamura S. Thiamine therapy in Alzheimer's disease. *Metabolic Brain Disease*. 1996;11(1):89–94.
5. Lonsdale D, Shamberger RJ, Audhya T. Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study. *Neuro Endocrinology Letters*. 2002;23(4):303–308.
6. Nozaki S, et al. Thiamine tetrahydrofurfuryl disulfide improves energy metabolism and physical performance during physical-fatigue loading in rats. *Nutrition Research*. 2009;29(12):867–872.
7. Lonsdale D. A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. *Evidence-Based Complementary and Alternative Medicine*. 2006;3(1):49–59.

{% hint style="info" %}
**Editorial note:** This page describes mechanisms and published evidence. It is not medical advice and does not recommend doses. Suggest corrections or new sources via the feedback link.
{% endhint %}
